Cargando…

CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential

CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ziduo, Ju, Xinsheng, Silveira, Pablo A., Abadir, Edward, Hsu, Wei-Hsun, Hart, Derek N. J., Clark, Georgina J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568190/
https://www.ncbi.nlm.nih.gov/pubmed/31231400
http://dx.doi.org/10.3389/fimmu.2019.01312
_version_ 1783427214261354496
author Li, Ziduo
Ju, Xinsheng
Silveira, Pablo A.
Abadir, Edward
Hsu, Wei-Hsun
Hart, Derek N. J.
Clark, Georgina J.
author_facet Li, Ziduo
Ju, Xinsheng
Silveira, Pablo A.
Abadir, Edward
Hsu, Wei-Hsun
Hart, Derek N. J.
Clark, Georgina J.
author_sort Li, Ziduo
collection PubMed
description CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activation and homeostasis. Soluble CD83 (sCD83), which is elevated in the serum of patients with autoimmune disease and some hematological malignancies is reported to have an immune suppressive function. While CD83 is emerging as a promising immune modulator with therapeutic potential, some important aspects such as its ligand/s, intracellular signaling pathways and modulators of its expression are unclear. In this review we discuss the recent biological findings and the potential clinical value of CD83 based therapeutics in various conditions including autoimmune disease, graft-vs.-host disease, transplantation and hematological malignancies.
format Online
Article
Text
id pubmed-6568190
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65681902019-06-21 CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential Li, Ziduo Ju, Xinsheng Silveira, Pablo A. Abadir, Edward Hsu, Wei-Hsun Hart, Derek N. J. Clark, Georgina J. Front Immunol Immunology CD83 is a member of the immunoglobulin (Ig) superfamily and is expressed in membrane bound or soluble forms. Membrane CD83 (mCD83) can be detected on a variety of activated immune cells, although it is most highly and stably expressed by mature dendritic cells (DC). mCD83 regulates maturation, activation and homeostasis. Soluble CD83 (sCD83), which is elevated in the serum of patients with autoimmune disease and some hematological malignancies is reported to have an immune suppressive function. While CD83 is emerging as a promising immune modulator with therapeutic potential, some important aspects such as its ligand/s, intracellular signaling pathways and modulators of its expression are unclear. In this review we discuss the recent biological findings and the potential clinical value of CD83 based therapeutics in various conditions including autoimmune disease, graft-vs.-host disease, transplantation and hematological malignancies. Frontiers Media S.A. 2019-06-07 /pmc/articles/PMC6568190/ /pubmed/31231400 http://dx.doi.org/10.3389/fimmu.2019.01312 Text en Copyright © 2019 Li, Ju, Silveira, Abadir, Hsu, Hart and Clark. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Li, Ziduo
Ju, Xinsheng
Silveira, Pablo A.
Abadir, Edward
Hsu, Wei-Hsun
Hart, Derek N. J.
Clark, Georgina J.
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
title CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
title_full CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
title_fullStr CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
title_full_unstemmed CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
title_short CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
title_sort cd83: activation marker for antigen presenting cells and its therapeutic potential
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568190/
https://www.ncbi.nlm.nih.gov/pubmed/31231400
http://dx.doi.org/10.3389/fimmu.2019.01312
work_keys_str_mv AT liziduo cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential
AT juxinsheng cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential
AT silveirapabloa cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential
AT abadiredward cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential
AT hsuweihsun cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential
AT hartdereknj cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential
AT clarkgeorginaj cd83activationmarkerforantigenpresentingcellsanditstherapeuticpotential